{"id":"agn-210669-ophthalmic-solution-0-075","_chembl":{"chemblId":"CHEMBL4303670","moleculeType":"Small molecule","molecularWeight":"424.57"},"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T03:20:15.696Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123473,"model":"claude-sonnet-4-5-20250929"},"description":"AGN-210669 ophthalmic solution, 0.075% is an investigational eye drop developed by Allergan for ophthalmic conditions. The compound is in Phase 2 clinical development, though its specific molecular target, mechanism of action, and therapeutic indication have not been publicly disclosed.","indications":{"approved":[{"status":"investigational","condition":"Ophthalmic condition (unspecified)","patientPopulation":"Unknown"}]},"trialDetails":[{"nctId":"NCT00809848","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-02","conditions":"Ocular Hypertension, Glaucoma","enrollment":172},{"nctId":"NCT01001195","phase":"PHASE2","title":"Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-11","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":165}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"AGN-210669 ophthalmic solution, 0.075%","genericName":"AGN-210669 ophthalmic solution, 0.075%","companyName":"Allergan","companyId":"allergan","firstApprovalDate":"","aiSummary":"AGN-210669 ophthalmic solution is a small molecule medication. It is used to treat Glaucoma, Open-Angle, Ocular Hypertension, and Glaucoma, according to ClinicalTrials.gov.","enrichmentLevel":2,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}